Company Monitoring Page for EXACT-Sciences

latest headlines for company on cafepharma

Stocks That Battle Cancer Were The Best-Performing Biotechs In January
Yahoo/Benzinga
Fri, 01/30/15 - 02:34 pm
Tags:
Novartis, Celgene, Pharmacyclics, EXACT Sciences, Tesaro, Foundation Medicine, Bind Therapeutics, Kite Pharma, Celldex Therapeutics
Top 10 med tech market movers in 2014
Fierce Medical Devices
Thu, 01/22/15 - 09:42 am
Tags:
devices, EXACT Sciences, Edwards Lifesciences, Illumina, DexCom, Covidien, NuVasive, Intuitive Surgical, Steris, Sirona Dental Systems, Becton Dickinson
Biotech Investors Guide and Preview to the J.P. Morgan Healthcare Conference Part 2
TheStreet.com
Fri, 01/9/15 - 09:18 am
Tags:
biotech, JPMHC 2015, Juno Therapeutics, AbbVie, MannKind, EXACT Sciences, NewLink Genetics
The Nominees for Best Biotechnology Co. CEO of 2014 Are...
TheStreet.com
Fri, 12/12/14 - 09:37 am
Tags:
biotech, EXACT Sciences, Idenix, Prosensa, Agios Pharmaceuticals, Bluebird Bio, InterMune
Exact Sciences soars on colon cancer test ruling
Yahoo/AP
Sat, 10/11/14 - 08:21 am
Tags:
EXACT Sciences, colon cancer, Cologuard, diagnostics
Medicare Recommends $500 Reimbursement for Exact Sciences' Colon Cancer Test
TheStreet.com
Fri, 10/10/14 - 08:55 am
Tags:
Medicare, EXACT Sciences, Cologuard, colon cancer, Chembio Diagnostics
September Biotech Calendar
TheStreet.com
Tue, 08/26/14 - 10:08 am
Tags:
Keryx, Orexigen, AstraZeneca, Nektar, Salix, Alimera, Amarin, Merck, EXACT Sciences, NPS Pharmaceuticals
Most Popular News Headlines For Monday, August 11 2014
CP Wire
Tue, 08/12/14 - 09:13 am
Tags:
Celltrion, Remsima, Jannsen, Remicade, Invokamet, JNJ, Sanofi, Cologuard, MannKind, Afrezza, EXACT Sciences
Tue, 08/12/14 - 09:04 am
Tags:
Celltrion, Remsima, Jannsen, Remicade, Invokamet, JNJ, Sanofi, Cologuard, MannKind, Afrezza, EXACT Sciences
Exact Sciences Wins U.S. Approval for Colon Cancer Test
Bloomberg
Mon, 08/11/14 - 06:20 pm
Tags:
diagnostics, colon cancer, EXACT Sciences, Cologuard
FDA advisers back Exact Sciences colon cancer test
Yahoo/AP
Thu, 03/27/14 - 04:59 pm
Tags:
FDA, advisory panels, EXACT Sciences, colon cancer, Cologuard
FDA says Exact Sciences colorectal cancer screening tool study met objectives
Yahoo/Fly on the Wall
Mon, 03/24/14 - 09:58 am
Tags:
FDA, colorectal cancer, EXACT Sciences, Cologuard
3 Upcoming FDA Meetings You Should be Watching
Motley Fool
Sun, 03/23/14 - 09:45 am
Tags:
EXACT Sciences, Cologuard, Pfizer, dalbavancin, Cubist Pharmaceuticals, tedizolid phosphate
3 Biotechs With Major Catalysts Incoming
Motley Fool
Wed, 03/19/14 - 11:22 am
Tags:
dalbavancin, Durata Therapeutics, MannKind, Afrezza, Cologuard, EXACT Sciences
2014 Biotechnology Catalysts
Seeking Alpha
Fri, 01/10/14 - 08:14 am
Tags:
Chelsea Therapeutics, Durect Corporation, EXACT Sciences, Vanda, Pozen, Progenics, MannKind, FDA
Biotech volatility can mean danger or opportunity
Marketwatch
Wed, 10/23/13 - 02:40 pm
Tags:
biotech, EXACT Sciences
A Game-Changing Cancer Screen For Exact Sciences
Seeking Alpha
Tue, 05/21/13 - 12:09 pm
Tags:
EXACT Sciences, cancer
Why Exact Sciences Is Poised to Underperform
Motley Fool
Sat, 05/4/13 - 10:20 am
Tags:
EXACT Sciences
Exact Sciences Earnings: Here’s Why Investors are Not Happy Now
Wall St. Cheat Sheet
Wed, 05/1/13 - 11:03 am
Tags:
EXACT Sciences, earnings
Not Exactly What Investors Were Looking For
Motley Fool
Sun, 04/21/13 - 10:16 am
Tags:
EXACT Sciences, Cologuard, colon cancer

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.